Belmont, MA, United States of America

Fan Liao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fan Liao. Retrieved from https://idiyas.com/inventor/fan-liao-bam0i9zv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Fan Liao

Introduction

Fan Liao is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing critical health issues, including Alzheimer's Disease.

Latest Patents

Fan Liao holds a patent for "Anti-amyloid beta antibodies and methods of using the same." This inventive concept is related to antibodies, such as recombinant humanized and monoclonal antibodies. The patent outlines methods of making antibodies and their applications, specifically targeting and clearing amyloid-beta (Aβ) plaques in the brain. These antibodies are suitable for use in treating disorders like Alzheimer's Disease (AD).

Career Highlights

Fan Liao is associated with AbbVie Inc., a global biopharmaceutical company known for its innovative research and development. His work at AbbVie has positioned him as a key player in the fight against neurodegenerative diseases.

Collaborations

Some of his notable coworkers include Andrew J. McCluskey and Meha Chhaya. Their collaborative efforts contribute to advancing research in antibody therapies.

Conclusion

Fan Liao's innovative work in developing anti-amyloid beta antibodies represents a significant advancement in the treatment of Alzheimer's Disease. His contributions continue to impact the field of biotechnology and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…